Endocannabinoids and non-endocannabinoid fatty acid amides in cirrhosis

Liver Int. 2010 Jul;30(6):780-1. doi: 10.1111/j.1478-3231.2010.02244.x. Epub 2010 Apr 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amides
  • Arachidonic Acids / metabolism
  • Biomarkers / blood
  • Cannabinoid Receptor Modulators / blood
  • Cannabinoid Receptor Modulators / metabolism*
  • Endocannabinoids*
  • Ethanolamines / metabolism
  • Glycerides / metabolism
  • Hemodynamics
  • Humans
  • International Normalized Ratio
  • Liver / blood supply
  • Liver / metabolism*
  • Liver / physiopathology
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / metabolism*
  • Liver Cirrhosis / physiopathology
  • Oleic Acids
  • Palmitic Acids / metabolism
  • Polyunsaturated Alkamides / metabolism
  • Severity of Illness Index
  • Up-Regulation

Substances

  • Amides
  • Arachidonic Acids
  • Biomarkers
  • Cannabinoid Receptor Modulators
  • Endocannabinoids
  • Ethanolamines
  • Glycerides
  • Oleic Acids
  • Palmitic Acids
  • Polyunsaturated Alkamides
  • N-oleoylethanolamine
  • palmidrol
  • glyceryl 2-arachidonate
  • anandamide